| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 129, Issue 6 2603-2607, Copyright © 1982 by American Association of Immunologists
ARTICLES |
Z Fishelson and HJ Muller-Eberhard
We demonstrate that nickel++ (Ni) can replace Mg in the formation of the C3b,Bb enzyme, and that Ni is more efficient in enzyme formation than Mg. C3b-bearing sheep erythrocytes (EC3b) were used to measure radiolabeled Factor B uptake and C3 convertase activity. Up to nine times more Factor B was specifically bound to EC3b in the presence of Ni than in the presence of Mg under identical conditions. To form one effective hemolytic site (1 Z) per EC3b cell with Ni, three times less Factor B, 12 times less Factor D, and 66 times less metal ion were required than when using Mg. The C3b,Bb formed with Ni (C3b,Bb(Ni)) had a 5 to 10 times longer half-life at different temperatures than the enzyme formed with Mg (C3b,Bb(Mg)). Native properdin stabilized C3b,Bb(Ni) to the same extent as C3b,Bb(Mg) (four to five times) and Factor H accelerated similarly the decay of both enzymes. Ni could also replace Mg in the formation of the C4b,2a enzyme. C4b,2a formation was measured by using C1 and C4b-bearing sheep erythrocytes (EAC1,4b) and native C2. To form 1 Z per EAC1,4b cell with Ni, two times less C2 and 60 times less metal ion were required than when using Mg. The half-life of the C4b,2a formed with Ni was two times longer than that formed with Mg. Decay of both C3b,Bb and C4b,2a enzymes formed either with Mg or with Ni was unaffected by EDTA. These results show that Ni is more efficient than Mg in the generation of both enzymes and suggest that Ni binds to the Mg-binding sites of the enzymes with a higher affinity than Mg.
This article has been cited by other articles:
|
|
 |
|
  S. M. Mangsbo, J. Sanchez, K. Anger, J. D. Lambris, K. N. Ekdahl, A. S. Loskog, B. Nilsson, and T. H. Totterman Complement Activation by CpG in a Human Whole Blood Loop System: Mechanisms and Immunomodulatory Effects J. Immunol., November 15, 2009; 183(10): 6724 - 6732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Ferreira, A. P. Herbert, H. G. Hocking, P. N. Barlow, and M. K. Pangburn Critical Role of the C-Terminal Domains of Factor H in Regulating Complement Activation at Cell Surfaces J. Immunol., November 1, 2006; 177(9): 6308 - 6316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Andersson, K. N. Ekdahl, R. Larsson, U. R. Nilsson, and B. Nilsson C3 Adsorbed to a Polymer Surface Can Form an Initiating Alternative Pathway Convertase J. Immunol., June 1, 2002; 168(11): 5786 - 5791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Pangburn, K. L. W. Pangburn, V. Koistinen, S. Meri, and A. K. Sharma Molecular Mechanisms of Target Recognition in an Innate Immune System: Interactions Among Factor H, C3b, and Target in the Alternative Pathway of Human Complement ,2 J. Immunol., May 1, 2000; 164(9): 4742 - 4751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Hourcade, L. M. Mitchell, and T. J. Oglesby Mutations of the Type A Domain of Complement Factor B That Promote High-Affinity C3b-Binding J. Immunol., March 1, 1999; 162(5): 2906 - 2911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wright and S. L. Morrison Effect of C2-Associated Carbohydrate Structure on Ig Effector Function: Studies with Chimeric Mouse-Human IgG1 Antibodies in Glycosylation Mutants of Chinese Hamster Ovary Cells J. Immunol., April 1, 1998; 160(7): 3393 - 3402. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
